pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,971 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 201 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: grant×type: phase readout×type: earnings×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa201
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07076342: The Role of mGluR5 in CBT-I

    Sponsor: Stony Brook University. Phase: PHASE4. Conditions: Major Depressive Disorder (MDD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06693986: Adenovirus (RGDCRAdCOX2F)

    Sponsor: Masonic Cancer Center, University of Minnesota. Phase: PHASE1. Conditions: Adenocarcinoma of Pancreas

    full page →ctgov ↗
    ›AVAILABLEphase readoutNCT03773770: Expanded Access to Triheptanoin

    Sponsor: Ultragenyx Pharmaceutical Inc. Phase: . Conditions: Long Chain Fatty Acid Oxidation Disorders

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT06648473: Repeatability of Magnetic Resonance Imaging in Patients With IDH1 Mutant Glioma on Ivosidenib

    Sponsor: Duke University. Phase: NA. Conditions: Low Grade Glioma of Brain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07251673: Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Dravet Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06854367: Accelerated vs. Conventional Theta Burst Stimulation for Late-life Depression

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Late Life Depression (LLD), Depression - Major Depressive Disorder, Depressive Disorder, Treatment-Resistant, Mood Disorders

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03796767: Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer

    Sponsor: University of Utah. Phase: PHASE2. Conditions: Recurrent Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lymph Nodes, Oligometastasis, Prostate Adenocarcinoma, PSA Failure

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00086567: Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

    Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Fallopian Tube Cancer, Peritoneal Neoplasms, Epithelial Ovarian Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07179107: Adequate Hydration and Health Outcomes

    Sponsor: Arizona State University. Phase: NA. Conditions: Dehydration, Dehydration (Physiology), Glucose Abnormalities, Cardiovascular

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07327307: Real World Evidence Study of SYN023 in Children Exposed to Rabies

    Sponsor: Synermore Biologics (Suzhou) Co., Ltd.. Phase: . Conditions: Rabies Post-exposure Prophylaxis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07609511: Magnet System Gastric Outlet Obstruction Study

    Sponsor: GT Metabolic Solutions, Inc.. Phase: NA. Conditions: Gastric Outlet Obstruction

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06505811: Mixed Methods Evaluation of the Pomona Household Universal Grant (HUG) Program

    Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Early Child Well-being, Parental Stress, Family Economic Security, Parental/Caregiver Health, Mental Health

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07407465: Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.

    Sponsor: Gruppo Oncologico del Nord-Ovest. Phase: PHASE2. Conditions: Colorectal Cancer, Colorectal Adenocarcinoma, Rectal Adenocarcinoma, Rectal Cancer, Adenocarcinoma, Rectal Cancer, Metastatic, Colon Cancer Metastatic, Colon Cancer Adenocarcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06532565: Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors

    Sponsor: Gilead Sciences. Phase: PHASE1. Conditions: Advanced Solid Tumors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07032467: Social Media Addiction and Compulsive Exercise Behaviors

    Sponsor: Saglik Bilimleri Universitesi. Phase: . Conditions: Healthy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06687967: A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)

    Sponsor: Sanofi. Phase: PHASE3. Conditions: Lichen Simplex Chronicus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07380607: Double Triggering Asynchrony in Mechanically Ventilated Patients.

    Sponsor: Mansoura University. Phase: . Conditions: Respiratory Failure, Critical Illness, Mechanical Ventilation

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07055607: A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice

    Sponsor: Novo Nordisk A/S. Phase: . Conditions: Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07576907: Ayre's Sensory-Motor Integration Exercises and Sensory Modulation And Motor Skills In Children With ASD

    Sponsor: Riphah International University. Phase: NA. Conditions: Motor Skills Disorders, Sensory Processing Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04066192: Brexpiprazole in Alcohol Use Disorder

    Sponsor: University of Colorado, Denver. Phase: PHASE2. Conditions: Alcohol Use Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07394192: Short-Course Radiotherapy With Tumor-Draining Lymph Node Preservation Followed by PD-1 Inhibitors in pMMR/MSS Stage II-III Rectal Cancer

    Sponsor: Peking University Cancer Hospital & Institute. Phase: PHASE2. Conditions: Rectal Cancer, Radiotherapy, PD-1 Inhibitor

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07480811: The Effect of the DASH Diet on Clinical and Metabolic Parameters in Children With MASLD

    Sponsor: Antalya Training and Research Hospital. Phase: NA. Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07445607: "Mulligan Technique vs Phonophoresis With Chitosan for Patellofemoral Pain"

    Sponsor: Ahram Canadian University. Phase: NA. Conditions: Patellofemoral Pain Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07331207: The Effect of 3D Printed Framework Bone-Borne Rapid Maxillary Expander in Young Adults

    Sponsor: Mansoura University. Phase: NA. Conditions: Bone Anchored Miniscrew Assisted Rapid Palatal Expansion

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07569536: Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock

    Sponsor: Hospices Civils de Lyon. Phase: PHASE3. Conditions: Septic Shock, Vasopressor Resistance

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06210711: Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center

    Sponsor: Baylor Research Institute. Phase: NA. Conditions: Traumatic Injury, PTSD, Posttraumatic Stress Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07595211: Apically Positioned Flap vs Rolled Flap for Soft Tissue Management During Implant Second-Stage Surgery

    Sponsor: Ohio State University. Phase: NA. Conditions: Dental Implant

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07462611: HIV Pre-Exposure Prophylaxis (PrEP) Linkage With Immediate Medications in the Emergency Department Study

    Sponsor: University of Texas Southwestern Medical Center. Phase: NA. Conditions: HIV Pre-exposure Prophylaxis, PrEP

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07557511: Transcutaneous Electrical Nerve Stimulation Versus Repetitive Transcranial Magnetic Stimulation on Pain and Functional Outcome in Cervical Radiculopathy

    Sponsor: Cairo University. Phase: NA. Conditions: Cervical Radiculopathy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04530565: Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

    Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07540507: Data Collection of the TUVA BX and iCover Stent Grafts Implanted During Branched Endovascular Aortic Repair (BEVAR)

    Sponsor: JOTEC GmbH. Phase: . Conditions: TAAA, AAA - Abdominal Aortic Aneurysm

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07512492: Combination Effect of Proprioceptive Training and Transcranial Magnetic Stimulation on Selected Gait Kinematic Parameters in Stroke Patients

    Sponsor: Cairo University. Phase: NA. Conditions: Transcranial Magnetic Stimulation, Stroke, Gait Disorders, Neurologic, Proprioceptive Training

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07502092: Mindfulness in Motion Targeted to Sustaining the Mental and Physical Resilience of First Responders

    Sponsor: Ohio State University. Phase: NA. Conditions: Stress, Resilience and Mental Health of First Responders, Work Engagement, Musculoskeletal Discomfort, First Responders

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07533292: Bacteriophage Therapy for Orthopedic Implant-Associated Infections

    Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: PHASE3. Conditions: Orthopedic, Implant Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04732065: ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

    Sponsor: Sabine Mueller, MD, PhD. Phase: PHASE1. Conditions: Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma, Recurrent Malignant Central Nervous System Neoplasm, Spinal Cord Glioma, World Health Organization (WHO) Grade III Glioma, CNS Tumor, Central Nervous System Tumor

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02652767: Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation

    Sponsor: GenSight Biologics. Phase: PHASE3. Conditions: Optic, Atrophy, Hereditary, Leber

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07606807: rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window

    Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: PHASE3. Conditions: Acute Ischemic Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06543407: Harm Reduction for Smokers With Mental Illness

    Sponsor: Dartmouth-Hitchcock Medical Center. Phase: NA. Conditions: Tobacco Dependence

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05698992: Rehabilitation and Recovery for Persons With Esophageal or Gastric Cancer

    Sponsor: Region Skane. Phase: . Conditions: Esophageal Cancer, Esophageal Neoplasms, Gastric Cancer, Stomach Neoplasm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02838836: Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

    Sponsor: University of Missouri-Columbia. Phase: . Conditions: Non-small Cell Lung Cancer, Esophageal Cancer, Gastric Cancer, Pancreatic Cancer, Hepatocellular Cancer, Colorectal Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03317392: Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07309536: Mediterranean Diet Uptake and Nutrition on Child Health, Inflammation, and Early-life Symbiosis (MUNCHIES) Study

    Sponsor: University of New Brunswick. Phase: NA. Conditions: Gut Microbiome, Body Composition, Adherence, Metabolites, Inflammation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06818136: Bladder EpiCheck European Haematuria Study

    Sponsor: Nucleix Ltd.. Phase: . Conditions: Hematuria, Cystoscopy, Urothelial Carcinoma Bladder, Urothelial Carcinoma of the Renal Pelvis and Ureter, Urothelial Carcinoma of the Urinary Bladder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07307911: Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy

    Sponsor: Damanhour University. Phase: PHASE2. Conditions: Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07551011: Impact of Behavioural Modification Working Toolkit Among Women With Gestational Diabetes Mellitus and Hypertension

    Sponsor: University of the Punjab. Phase: NA. Conditions: Gestational Diabetes Mellitus in Pregnancy, Hypertension ,Pregnancy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07449611: Comparative Impacts of Two Anesthesia Methods on Peripheral Tissue Oxygenation in the Upper Limb

    Sponsor: Sakarya University. Phase: NA. Conditions: Regional Anesthesia, Interscalene Blocks, Shoulder Surgery, Perfusion Index

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT02522611: Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain

    Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: PHASE1. Conditions: Intractable Pain, Palliative Care

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07207707: A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

    Sponsor: Kumquat Biosciences Inc.. Phase: PHASE1. Conditions: Solid Tumor Malignancies

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06114992: Servo-n HFOV Study: Safety and Performance in Neonates and Infants

    Sponsor: Maquet Critical Care AB. Phase: . Conditions: Elective HFOV for Respiratory Failure in Neonates/Infants, Rescue HFOV in Neonates and/Infants With Refractory Respiratory Failure Under Conventional Therapy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07330492: Testing a Brief Reassurance Message Before a Musculoskeletal Clinic Visit

    Sponsor: University of Texas at Austin. Phase: NA. Conditions: Any Non-traumatic Musculoskeletal Condition

    full page →ctgov ↗
    ← prev
    page 54 of 100
    next →